Standard name |
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP |
Systematic name |
M12889 |
Brief description |
Genes whose expression profile is specific to Cluster IIa of urothelial cell carcinoma (UCC) tumors. |
Full description or abstract |
We used gene expression profiling, mutation analyses of FGFR3 and TP53, and LOH analyses of chromosome 9 and the TP53 region on chromosome arm 17p, to molecularly characterize 75 Ta and T1 bladder carcinomas. We identified four major cellular processes related to cell cycle, protein synthesis, immune response, and extra cellular components that contribute to the expressional heterogeneity of early-stage urothelial cell carcinoma (UCC). Activating FGFR3 mutations were found at the highest frequency in G1 tumors (80%), and showed a strong correlation with FGFR3 expression. In contrast, G3 tumors displayed mutations in less than 10% of the cases and a low level of FGFR3 expression. Even though LOH on chromosome 9 was not associated with any specific expression pattern, our data indicate that loss of chromosome 9 is associated with tumor development rather than initiation. The combined analyses suggest the existence of two types of UCC tumors, one which is characterized by FGFR3 mutation or expression, high expression of protein synthesis genes, and low expression of cell cycle genes. Furthermore, the presented data underscore FGFR3 receptor involvement in urothelial cell transformation as the presence of FGFR3 mutations has a major impact on the global gene expression profile of bladder carcinomas. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 16532037 Authors: Lindgren D,Liedberg F,Andersson A,Chebil G,Gudjonsson S,Borg A,Månsson W,Fioretos T,Höglund M |
Exact source |
Table 2CS |
Related gene sets |
(show 8 additional gene sets from the source publication)
(show 9 gene sets from the same authors)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Leona Saunders (MSigDB Team) |
Source platform or identifier namespace |
Human_NCBI_Gene_ID |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 8 genes
|
Gene families ? |
Categorize these
8 genes by gene family
|
Show members |
(show 8 source identifiers mapped to 8 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
153 |
153 |
ADRB1 |
adrenoceptor beta 1 [Source:HGNC Symbol;Acc:HG... |
1609 |
1609 |
DGKQ |
diacylglycerol kinase theta [Source:HGNC Symbo... |
25 |
25 |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine ki... |
3898 |
3898 |
LAD1 |
ladinin 1 [Source:HGNC Symbol;Acc:HGNC:6472] |
57111 |
57111 |
RAB25 |
RAB25, member RAS oncogene family [Source:HGNC... |
6275 |
6275 |
S100A4 |
S100 calcium binding protein A4 [Source:HGNC S... |
6623 |
6623 |
SNCG |
synuclein gamma [Source:HGNC Symbol;Acc:HGNC:1... |
8528 |
8528 |
DDO |
D-aspartate oxidase [Source:HGNC Symbol;Acc:HG... |
|
Version history |
|